Fidelity Investments
NEPH icon

Fidelity Investments’s Nephros NEPH Stock Holding History

Fidelity Investments’s Portfolio NEPH Stock Details NEPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22 Buy
+6
New +$20 ﹤0.01% 5503
2022
Q1 		– Sell
-91
Closed -$1K – 5305
2021
Q4 		$1K Hold
91
– – ﹤0.01% 4167
2021
Q3 		$1K Buy
+91
New +$789 ﹤0.01% 4167

Other funds holding NEPH

WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CC
Cornerstone Capital Palo Alto, California $1.12B AUM 28.84% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Fidelity Investments's NEPH Position: Q2 2026 in Review

Fidelity Investments opened a new position in Nephros (NEPH) in Q2 2026: 6 shares worth $22. The stake represents ﹤0.01% of the portfolio and ranks #5503 among its holdings. This is a return to the name: Fidelity Investments previously reported a position in NEPH as recently as Q4 2021.

Fidelity Investments first reported a position in NEPH in Q3 2021 and has held it in 3 quarters since. The position peaked at $1K in Q4 2021. 33 funds tracked by Wall St. Rank hold NEPH as of Q2 2026.

  • Fidelity Investments held 6 shares of Nephros worth $22 as of Q2 2026.
  • Nephros was a new Fidelity Investments position in Q2 2026.
  • Nephros made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #5503 holding.
  • Fidelity Investments first reported a position in Nephros in Q3 2021 and has held it in 3 quarters since.
  • Fidelity Investments's Nephros position peaked at $1K in Q4 2021.
  • 33 funds tracked by Wall St. Rank held Nephros as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.